Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Pawlak

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Biochemical Pharmacology|December 1, 1979
In vitro binding of metabolically activated [14C]-ledakrin, or 1-nitro-9-14C-(3'-dimethylamino-N-propylamino) acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cellsJ W Pawlak, J Konopa
Pneumonologia I Alergologia Polska|January 1, 1996
[Results of treating patients with pleural empyema in relation to time of diagnosis]W Lambrecht, W Pawlak, J Pepliński
Chemico-Biological Interactions|April 1, 1976
Covalent binding of 1-nitro-9-(3-dimethyl-n-propylamino) acridine, a new antitumor drug, to DNA of Ehrlich ascites tumor cells in vivoJ Konopa, K Koldej, J W Pawlak
Chemico-Biological Interactions|February 1, 1983
The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cellsJ W Pawlak, K Pawlak, J Konopa
Chemico-Biological Interactions|February 1, 1983
The mode of action of cytotoxic and antitumor 1-nitroacridines. III. In vivo interstrand cross-linking of DNA of mammalian or bacterial cells by 1-nitroacridinesJ Konopa, J W Pawlak, K Pawlak
Cancer Research|October 1, 1984
Cytotoxic and antitumor activity of 1-nitroacridines as an aftereffect of their interstrand DNA cross-linkingK Pawlak, J W Pawlak, J Konopa
Cancer Treatment Reviews|September 28, 2000
Antisense therapy in cancerW Pawlak, J Zolnierek, T Sarosiek, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|September 24, 2004
Endothelial protection from reperfusion injury by ischemic preconditioning and diazoxide involves a SOD-like anti-O2- mechanismM Maczewski, M Duda, W Pawlak, et al.
Artificial Intelligence in Medicine|February 1, 1996
Determining and classifying the region of interest in ultrasonic images of the breast using neural networksD Buller, A Buller, P R Innocent, et al.
Chemico-Biological Interactions|February 1, 1983
The mode of action of cytotoxic and antitumor 1-nitroacridines. I. The 1-nitroacridines do not exert their cytotoxic effects by physicochemical binding with DNAK Pawlak, A Matuszkiewicz, J W Pawlak, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biochemical Pharmacology|December 1, 1979
In vitro binding of metabolically activated [14C]-ledakrin, or 1-nitro-9-14C-(3'-dimethylamino-N-propylamino) acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cellsJ W Pawlak, J Konopa
Pneumonologia I Alergologia Polska|January 1, 1996
[Results of treating patients with pleural empyema in relation to time of diagnosis]W Lambrecht, W Pawlak, J Pepliński
Chemico-Biological Interactions|April 1, 1976
Covalent binding of 1-nitro-9-(3-dimethyl-n-propylamino) acridine, a new antitumor drug, to DNA of Ehrlich ascites tumor cells in vivoJ Konopa, K Koldej, J W Pawlak
Chemico-Biological Interactions|February 1, 1983
The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cellsJ W Pawlak, K Pawlak, J Konopa
Chemico-Biological Interactions|February 1, 1983
The mode of action of cytotoxic and antitumor 1-nitroacridines. III. In vivo interstrand cross-linking of DNA of mammalian or bacterial cells by 1-nitroacridinesJ Konopa, J W Pawlak, K Pawlak
Cancer Research|October 1, 1984
Cytotoxic and antitumor activity of 1-nitroacridines as an aftereffect of their interstrand DNA cross-linkingK Pawlak, J W Pawlak, J Konopa
Cancer Treatment Reviews|September 28, 2000
Antisense therapy in cancerW Pawlak, J Zolnierek, T Sarosiek, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|September 24, 2004
Endothelial protection from reperfusion injury by ischemic preconditioning and diazoxide involves a SOD-like anti-O2- mechanismM Maczewski, M Duda, W Pawlak, et al.
Artificial Intelligence in Medicine|February 1, 1996
Determining and classifying the region of interest in ultrasonic images of the breast using neural networksD Buller, A Buller, P R Innocent, et al.
Chemico-Biological Interactions|February 1, 1983
The mode of action of cytotoxic and antitumor 1-nitroacridines. I. The 1-nitroacridines do not exert their cytotoxic effects by physicochemical binding with DNAK Pawlak, A Matuszkiewicz, J W Pawlak, et al.
Pageof 3